Nivolumab versus Docetaxel in Advanced Non-squamous Non-small Cell Lung Cancer

BACKGROUND: Options for patients with non-squamous non-small cell lung cancer (NSCLC) whose disease progresses after first-line chemotherapy are limited. This randomized, open-label, international phase 3 study evaluated efficacy and safety of nivolumab versus docetaxel in this patient population af...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:N Engl J Med
Prif Awduron: Borghaei, Hossein, Paz-Ares, Luis, Horn, Leora, Spigel, David R., Steins, Martin, Ready, Neal E., Chow, Laura Q., Vokes, Everett E., Felip, Enriqueta, Holgado, Esther, Barlesi, Fabrice, Kohlhäufl, Martin, Arrieta, Oscar, Burgio, Marco Angelo, Fayette, Jérôme, Lena, Hervé, Poddubskaya, Elena, Gerber, David E., Gettinger, Scott N., Rudin, Charles M., Rizvi, Naiyer, Crinò, Lucio, Blumenschein, George R., Antonia, Scott J., Dorange, Cécile, Harbison, Christopher T., Finckenstein, Friedrich Graf, Brahmer, Julie R.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2015
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5705936/
https://ncbi.nlm.nih.gov/pubmed/26412456
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1507643
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg